scispace - formally typeset
P

Paul J. van Diest

Researcher at Utrecht University

Publications -  514
Citations -  22750

Paul J. van Diest is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 70, co-authored 459 publications receiving 18892 citations. Previous affiliations of Paul J. van Diest include University Medical Center Utrecht & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer

TL;DR: Recent developments in the application of mitotic inhibitors for mCRPC are summarized from a clinical perspective and four main groups of inhibitors currently being tested in clinical trials are microtubule-inhibitors, polo-like kinase 1 inhibitors, aurora kinase inhibitors and kinesin-spindle protein inhibitors.
Journal ArticleDOI

Improved cytodiagnostics and quality of patient care through double reading of selected cases by an expert cytopathologist.

TL;DR: The results emphasize that cy topathology is a subspecialization of pathology and requires specialized cytopathologists, and this double reading strategy is worthwhile and contributes to better cytodiagnostics and quality of patient care, especially for suspicious pleural fluid, thyroid and urine specimens.
Journal ArticleDOI

Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas discovered by Machine Learning.

TL;DR: A machine learning pipeline to extract CMBs from whole slide images of tissue histology is developed and validated a framework (CMS-ML) for CMS discovery in LGG associated with specific molecular alterations, immune micro-environment, prognosis, and treatment response.
Journal ArticleDOI

Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast

TL;DR: CCLs carry copy number changes of several known breast cancer-related genes, thereby substantiating their role in breast carcinogenesis, and among them, CCND1 and ESR1 copy number gains and CDH1copy number losses are of particular interest.